Sarah Beshar
Insider
First SEC filing: May 17, 2017 · Latest: May 17, 2017
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| May 15, 2026 | IVZ | A | 8,112 | · | · | 115,166 Direct | +7.58% | Acquired | (price as of 2026-10-02) |
| May 15, 2025 | IVZ | A | 12,728 | · | · | 107,035 Direct | +13.50% | Acquired | (price as of 2026-10-02) |
| May 15, 2024 | IVZ | A | 11,955 | · | · | 94,307 Direct | +14.52% | Acquired | (price as of 2026-10-02) |
| May 15, 2023 | IVZ | A | 12,820 | · | · | 82,352 Direct | +18.44% | Acquired | (price as of 2026-10-02) |
| May 15, 2022 | IVZ | A | 10,930 | · | · | 69,532 Direct | +18.65% | Acquired | (price as of 2026-10-02) |
| May 15, 2021 | IVZ | A | 5,807 | · | · | 58,602 Direct | +11.00% | Acquired | (price as of 2026-10-02) |
| April 29, 2021 | IVZ | A | 1,311 | · | · | 52,795 Direct | +2.55% | Acquired | (price as of 2026-10-02) |
| Jan. 27, 2021 | IVZ | A | 1,744 | · | · | 51,484 Direct | +3.51% | Acquired | (price as of 2026-10-02) |
| Oct. 28, 2020 | IVZ | A | 2,719 | · | · | 49,740 Direct | +5.78% | Acquired | (price as of 2026-10-02) |
| Sept. 2, 2020 | IVZ | P | 9,500 | $10.54 | $100,130 | 47,021 Direct | +25.32% | Acquired | 190.9% (price as of 2026-10-02) |
| July 29, 2020 | IVZ | A | 3,419 | · | · | 37,521 Direct | +10.03% | Acquired | (price as of 2026-10-02) |
| April 24, 2020 | IVZ | A | 4,647 | · | · | 34,102 Direct | +15.78% | Acquired | (price as of 2026-10-02) |
| Jan. 30, 2020 | IVZ | A | 2,056 | · | · | 29,123 Direct | +7.60% | Acquired | (price as of 2026-10-02) |
| Oct. 25, 2019 | IVZ | A | 2,126 | · | · | 26,783 Direct | +8.62% | Acquired | (price as of 2026-10-02) |
| July 26, 2019 | IVZ | A | 1,848 | · | · | 24,400 Direct | +8.19% | Acquired | (price as of 2026-10-02) |
| April 26, 2019 | IVZ | A | 1,665 | · | · | 22,406 Direct | +8.03% | Acquired | (price as of 2026-10-02) |
| Feb. 22, 2019 | IVZ | P | 5,270 | $18.97 | $99,972 | 20,601 Direct | +34.37% | Acquired | 61.6% (price as of 2026-10-02) |
| Jan. 31, 2019 | IVZ | A | 1,989 | · | · | 15,331 Direct | +14.91% | Acquired | (price as of 2026-10-02) |
| Oct. 19, 2018 | IVZ | A | 1,649 | · | · | 13,235 Direct | +14.23% | Acquired | (price as of 2026-10-02) |
| July 27, 2018 | IVZ | A | 1,395 | · | · | 11,521 Direct | +13.78% | Acquired | (price as of 2026-10-02) |
| April 27, 2018 | IVZ | A | 1,225 | · | · | 10,085 Direct | +13.83% | Acquired | (price as of 2026-10-02) |
| Feb. 27, 2018 | IVZ | P | 2,970 | $33.32 | $98,960 | 8,837 Direct | +50.62% | Acquired | -8.0% (price as of 2026-10-02) |
| Feb. 1, 2018 | IVZ | A | 1,006 | · | · | 5,867 Direct | +20.70% | Acquired | (price as of 2026-10-02) |
| Oct. 26, 2017 | IVZ | A | 982 | · | · | 4,848 Direct | +25.40% | Acquired | (price as of 2026-10-02) |
| July 28, 2017 | IVZ | A | 601 | · | · | 3,866 Direct | +18.41% | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| May 17, 2017 | IVZ | Common Shares | 3,265 | Direct |